Investor · Tel Aviv, L3

Matthew Frankel

Open Matthew in the network graph →

Filings

2

SEC Form D

Connections

20

co-filers

Capital

$10.0M

across filings

Active

Aug 2024

to Mar 2026

Most-connected co-filers (20)

Dean Delisle · Macclenny, FL1 shared Tony K. Cox · MYRTLE BEACH, SC1 shared Jonathan Propper · Philadelphia, PA1 shared Todd Sandler · Philadelphia, PA1 shared Larry Braden · PALO ALTO, CA1 shared Neil H. Cohen · Cambridge, MA1 shared Claude C. Nicaise · Cheshire, CT1 shared Joseph B. Lipscomb · Fort Worth, TX1 shared Whitney Imeraj · Atlanta, GA1 shared John Makarewicz · Naples, FL1 shared Leonard Schrage · Los Angeles, CA1 shared Alastair Dorward · Elk Grove Village, IL1 shared John Bailey · San Francisco, CA1 shared Spencer Moslow · San Francisco, CA1 shared Franz S. Guenter · Colchester, VT1 shared Alan C. Moses · Tel Aviv, L31 shared Adi Mor · Tel Aviv, L31 shared Sigal Fattal · Ramat Gan, L31 shared Jill H. Quigley · Tel Aviv, L31 shared Nissim Darvish · Omer, L31 shared

Recent filings (2)

Nocion Therapeutics, Inc.Mar 2026 · 9 co-filers$23.0M Chemomab Therapeutics Ltd.Aug 2024 · 17 co-filers$10.0M Chemomab Therapeutics Ltd.Aug 2024 · 17 co-filers$10.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →